← Back to flashcards

IV induction agents

Propofol, thiopentone, etomidate and ketamine side by side — presentation, pharmacokinetics, organ effects, indications and the contraindications that get examined.

Propofol vs thiopentone

The two classic induction agents. Note the opposite pH: propofol is near-neutral, thiopentone is strongly alkaline — which explains most of its hazards.

PropofolThiopentone
ClassAlkyl phenolThiobarbiturate
PresentationWhite lipid emulsion — 10% soyabean oil, 2.25% glycerol, 1.2% purified egg phosphatide, sodium hydroxide, waterPale yellow powder, 2.5% solution. Rubber-bunged bottle with nitrogen in it to prevent oxidation
pH6–8.510.5 — strongly alkaline
pKa117.6
IonisationLargely un-ionised at pH 7.499.9% ionised in the vial at pH 10.5; in blood at pH 7.4 about 61% is un-ionised and therefore lipid soluble
Induction dose1.5–2 mg/kg4–6 mg/kg
Infusion doses4–12 mg/kg/h anaesthesia · 0.3–4 mg/kg/h sedationNot used as an infusion (zero-order kinetics)
Protein binding98%80%
Onset30 secondsOne arm–brain circulation — very rapid
DurationAbout 10 minutes (redistribution)5–10 minutes (redistribution)
Vd4 L/kg2.5 L/kg
Elimination t½5–12 hours6–15 hours
Clearance30–60 ml/kg/min — exceeds hepatic blood flow, so there is extrahepatic metabolism3.5 ml/kg/min
MetabolismHepatic oxidation and conjugation, plus extrahepaticHepatic oxidation
ExcretionUrine, <1% unchangedUrine, <1% unchanged

Why thiopentone's chemistry matters

  • Replacing the oxygen with a sulphur atom (thio-) gives rapid onset, short duration and quick recovery, by markedly increasing lipid solubility.
  • It is 2× more lipid soluble than the barbiturate parent and crosses the blood–brain barrier readily.
  • Because it is un-ionised drug that is lipid soluble, and 61% is un-ionised at pH 7.4, acidosis increases the un-ionised fraction and deepens the effect.
  • The pH of 10.5 means extravasation or intra-arterial injection causes vasoconstriction, thrombosis and tissue necrosis.

Organ effects compared

  • CNS: Both reduce ICP, CMRO₂ and cerebral blood flow. Thiopentone is additionally anticonvulsant. Both reduce EEG activity.
  • Respiratory: Propofol causes marked respiratory depression and obtunds airway reflexes well. Thiopentone depresses respiration but is more likely to cause laryngospasm because reflexes are less well suppressed.
  • CVS: Both cause ↓BP, ↓SVR and ↓CO. Propofol produces bradycardia; thiopentone produces a compensatory tachycardia.
  • Renal: Propofol may cause green urine. Thiopentone reduces renal plasma flow, raises ADH and reduces urine output.
  • GI: Propofol is antiemetic. Thiopentone causes splanchnic vasoconstriction.
  • Obstetrics: Propofol has high placental transfer; thiopentone is considered safe and was long the agent of choice.

The safety headlines

  • Propofol is SAFE in malignant hyperthermia and in porphyria. This is a favourite exam point.
  • Thiopentone is CONTRAINDICATED in porphyria — barbiturates induce ALA synthase. It is also contraindicated where there is airway obstruction or a fixed cardiac output state.
  • Thiopentone is the agent of choice in thyrotoxicosis — it has antithyroid activity.
  • Propofol infusion syndrome (PRIS) occurs above about 4 mg/kg/h for more than 48 hours. Thiopentone does not cause it.
  • Propofol causes pain on injection; thiopentone causes tissue necrosis on extravasation.

Etomidate vs ketamine

The two agents reached for when the patient is unstable — but for opposite reasons and with opposite haemodynamic mechanisms.

EtomidateKetamine
ClassCarboxylated imidazolePhencyclidine derivative
MechanismGABA-A agonistNon-competitive NMDA antagonist
Main effectHypnosisDissociative anaesthesia
pH8.13.5–5.5
pKa4.1 — largely un-ionised at pH 7.47.5
Dose IV0.2–0.3 mg/kg1–2 mg/kg
Dose IMNot used10 mg/kg
Onset30–60 s30 s IV · 2–8 min IM
Duration3–5 min5–10 min IV · 10–20 min IM
Protein binding75%25%
Vd2.5–4.5 L/kg3 L/kg
MetabolismHepatic and plasma esterasesHepatic — norketamine is active, about 30% of parent potency
Elimination t½2–5 hours3 hours
CVSCardiovascularly stable — BP, HR and CO maintained↑HR, ↑BP, ↑CO via sympathetic stimulation
RespiratoryMinimal respiratory depressionMinimal depression; airway reflexes PRESERVED; bronchodilator
Cerebral↓CBF, ↓CMRO₂, ↓ICP↑CBF, ↑CMRO₂, ↑ICP
AirwayDepressedPreserved
Etomidate — side effectsKetamine — side effects
Myoclonus
PONV (high incidence)
Cough and hiccup
Adrenal suppression — inhibits 11-β-hydroxylase
Inhibits platelet function
Venous thrombosis
Porphyria
Pain on injection
Emergence delirium
Hallucinations
↑Salivation
↑PONV
↑Uterine tone
↑ICP and ↑IOP
Hypertension and tachycardia

Indications and contraindications

  • Etomidate — indications: the haemodynamically unstable patient, cardiac patients, shock, raised ICP, and shunt (cardiac) cases. Also used for ECT, as it lowers the seizure threshold.
  • Etomidate — contraindications: porphyria and adrenal suppression. Avoid in septic shock, where adrenal suppression is most harmful.
  • Ketamine — indications: trauma, burns, asthma, and neuropathic pain. Also for the hypotensive or hypovolaemic patient.
  • Ketamine — contraindications: hypertension, raised ICP, and ischaemic heart disease (it increases myocardial oxygen demand).
  • S-ketamine is more potent than the racemic mixture — roughly twice the potency with fewer psychotomimetic effects.

Clonidine — the sedative that isn't an induction agent

  • α₂ agonist, highly lipid soluble, and crosses the blood–brain barrier readily — which is why it produces central sedation and analgesia.
  • Provides sedation and analgesia without significant respiratory depression, plus sympatholysis.
  • Presynaptic α₂ stimulation inhibits noradrenaline release — the mechanism behind the fall in heart rate and blood pressure.
  • Dexmedetomidine is the more selective modern equivalent and reduces ICU delirium compared with benzodiazepines.

Built from handwritten pages IMG_1280–1282, 1284, 1285.